Home

Latest Galen Institute Features

Competition in Medicare Advantage, Part D, and “Extra Help”/ Working together for seniors and taxpayers

Seniors are beginning to get fliers in the mail alerting them to the upcoming open season for enrollment in Medicare Advantage and Medicare Part D prescription drug plans.  Both programs rely on competition and consumer choice to increase options and hold down costs for seniors.  Open season begins October 15 for those planning to enroll […]

Read More

More Competition is the Best Cure

The most interesting thing about the PR disaster involving Mylan’s life-saving EpiPen is probably the least discussed—namely that drugs don’t cost what people think they do. Faced with a barrage of criticism for EpiPen price hikes, from about $100 in 2009 to more than $600 today, Mylan’s CEO Heather Bresch explains that her company gets less than […]

Read More

Obamacare’s ‘Crown Jewel’ Loses Its Luster

Former Obama Administration official Donald Berwick once called the Center for Medicare and Medicaid Innovation (CMMI) “the jewel in the crown of health-care reform.” The metaphor is apt: CMMI, more than any other aspect of Obamacare, is an imperial enterprise. Congress established CMMI in the Obamacare statute with the goal of finding ways to reduce federal spending on medical […]

Read More

Obama Sabotages Obamacare

The ACA and the administration’s whack-a-mole regulations are responsible for double-digit premium increases and for the exodus of insurers from selling individual policies in the ObamaCare exchanges. As health insurers head for the exits, Americans who have been whipsawed by ObamaCare may get whacked again this fall:  First, they were thrown off private plans that […]

Read More